Publications
- Multitarget tacrine hybrids with neuroprotective properties to confront Alzheimer's disease2017 | Publication without faculty affiliation
- Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy2017 | Publication without faculty affiliation
- Design, Synthesis and in vitro Evaluation of Indolotacrine Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease2016 | Publication without faculty affiliation
- Synthesis and biological evaluation of benzochromenopyrimidinones as cholinesterase inhibitors and potent antioxidant, non-hepatotoxic agents for Alzheimer's disease2016 | Publication without faculty affiliation
- The antioxidant additive approach for Alzheimer's disease therapy: New ferulic (Lipoic) acid plus melatonin modified tacrines as Cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 activators2016 | Publication without faculty affiliation
- Pharmacotherapy of Alzheimer's Disease: Current State and Future Perspectives2014 | Publication without faculty affiliation
- A Resurrection of 7-MEOTA: A Comparison with Tacrine2013 | Faculty of Pharmacy in Hradec Králové
- Tacrine and its derivatives in the therapy of Alzheimer's disease2012 | Publication without faculty affiliation
- Phenoxytacrine derivatives: Low-toxicity neuroprotectants exerting affinity to ifenprodil-binding site and cholinesterase inhibition2024 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- Nakagami imaging and morphing for multiple sclerosis lesion volume estimation2024 | Publication without faculty affiliation
Loading network view...